As of 2025-11-21, the EV/EBITDA ratio of Biodesix, Inc. (BDSX) is -2.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biodesix,'s latest enterprise value is 73.99 mil USD. Biodesix,'s TTM EBITDA according to its financial statements is -26.58 mil USD. Dividing these 2 quantities gives us the above Biodesix, EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 9.0x | 8.1x |
| Forward P/E multiples | 5.7x - 9.0x | 7.6x |
| Fair Price | (30.28) - (36.08) | (32.05) |
| Upside | -565.1% - -654.2% | -592.4% |
| Date | EV/EBITDA |
| 2025-11-20 | -2.78 |
| 2025-11-19 | -2.89 |
| 2025-11-18 | -2.97 |
| 2025-11-17 | -3.17 |
| 2025-11-14 | -3.19 |
| 2025-11-13 | -3.17 |
| 2025-11-12 | -3.18 |
| 2025-11-11 | -3.29 |
| 2025-11-10 | -3.07 |
| 2025-11-07 | -3.12 |
| 2025-11-06 | -3.14 |
| 2025-11-05 | -3.36 |
| 2025-11-04 | -3.08 |
| 2025-11-03 | -2.74 |
| 2025-10-31 | -2.87 |
| 2025-10-30 | -2.80 |
| 2025-10-29 | -2.79 |
| 2025-10-28 | -2.79 |
| 2025-10-27 | -2.82 |
| 2025-10-24 | -2.84 |
| 2025-10-23 | -2.76 |
| 2025-10-22 | -2.64 |
| 2025-10-21 | -2.87 |
| 2025-10-20 | -2.81 |
| 2025-10-17 | -2.76 |
| 2025-10-16 | -2.90 |
| 2025-10-15 | -3.03 |
| 2025-10-14 | -3.14 |
| 2025-10-13 | -3.03 |
| 2025-10-10 | -3.01 |
| 2025-10-09 | -3.15 |
| 2025-10-08 | -3.13 |
| 2025-10-07 | -3.00 |
| 2025-10-06 | -3.07 |
| 2025-10-03 | -3.12 |
| 2025-10-02 | -3.11 |
| 2025-10-01 | -3.10 |
| 2025-09-30 | -3.07 |
| 2025-09-29 | -3.12 |
| 2025-09-26 | -3.13 |
| 2025-09-25 | -3.20 |
| 2025-09-24 | -3.30 |
| 2025-09-23 | -3.22 |
| 2025-09-22 | -2.96 |
| 2025-09-19 | -2.95 |
| 2025-09-18 | -2.84 |
| 2025-09-17 | -2.70 |
| 2025-09-16 | -2.80 |
| 2025-09-15 | -3.08 |
| 2025-09-12 | -3.06 |